Promoters of Sudeep Pharma, India, complete acquisition of 50% shares from JRS Pharma, Germany, regaining 100% ownership.
Vadodara, India, July 8, 2024 – Sudeep Pharma Private Limited's promoters have completed the acquisition of shares from their joint venture partners - JRS PHARMA, regaining 100% ownership of the company. This strategic move represents a significant step in Sudeep Pharma’s ongoing growth and development, enabling the company to pursue its vision.Promoters of Sudeep Pharma, Mr. Sujit Bhayani & Family, entered into a joint venture in 2015 with JRS Pharma. Combining JRS Pharma’s expertise in excipients with Sudeep Pharma's technological advancements and robust manufacturing capabilities resulted in significant growth and valuable cooperation over the past nine years.Sudeep Pharma remains dedicated to delivering cutting-edge pharmaceutical solutions, maintaining the highest standards of qua...









